Showing 346 to 360 of 1610 results
HCPC response to PSA Performance Review
HCPC welcomes recognition of progress on key areas of activity and sets out plan for further improvement
Insights and data
Data and statistics on our regulatory work, including information on fitness to practise, registration and education processes
My Story - Dawn Starley
In celebration of LGBTQ+ History Month, Dawn shares what her experience has been both professionally and personally and why Equality, Diversity and Inclusion is critical for ensuring all members of society are given a fair chance to be themselves and flourish.
What our standards say
Learn what our standards say about supervision
Resources on record keeping
We have listed the main resources that we signpost registrants to, when they have a question about record keeping
Registration FAQs
Some of the questions we most frequently get asked by registrants
Our guidance on the use of social media
How to ensure you meet our standards by using social media effectively and sensitively
Profession specific information
Details of professional bodies who have produced profession specific guidance or information on preceptorship or related work.
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)